pISSN 1226-6051
eISSN 2508-786X

Table. 4.

Table. 4.

The association between types of statin and osteoporosis

Pitavastatin (n=1,008,368) Fluvastatin (n=995,718) Pravastatin (n=997,468) Lovastatin (n=995,127) Simvastatin (n=995,224) Atorvastatin (n=1,062,899) Rosuvastatin (n=1,054,119)
Control Reference Reference Reference Reference Reference Reference Reference
All statin users 1.06 (1.01-1.12) 0.99 (0.80-1.22) 0.99 (0.89-1.12) 0.44 (0.23-0.84) 0.88 (0.61-1.27) 0.93 (0.90-0.95) 0.95 (0.93-0.98)
Intensity
Low 0.94 (0.77-1.13) <0.01 (<0.01,>99.99) 0.88 (0.75-1.12) 0.47 (0.23-0.85) - N/A N/A
Moderate 1.07 (1.02-1.13) 0.99 (0.81-1.23) 1.20 (1.01-1.42) <0.01 (<0.01,>99.99) 0.88 (0.61-1.27) 0.93 (0.90-0.96) 0.96 (0.93-0.99)
High N/A N/A N/A N/A N/A 0.86 (0.76-0.97) 0.88 (0.81-0.96)

Adjusted OR; odds ratio adjusted by patients’ age, gender, insurance type, diabetes mellitus, fracture, rheumatoid arthritis, thyroid disease, ovarian hypofunction, and hormone replacement therapy

Korean J Clin Pharm 2021;31:278-84 https://doi.org/10.24304/kjcp.2021.31.4.278
© 2021 Korean J Clin Pharm